HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The proteomic signature of NPM/ALK reveals deregulation of multiple cellular pathways.

Abstract
Constitutive expression of the chimeric NPM/ALK fusion protein encoded by the t(2;5)(p32;q35) is a key oncogenic event in the pathogenesis of most anaplastic large cell lymphomas (ALCLs). The proteomic network alterations produced by this aberration remain largely uncharacterized. Using a mass spectrometry (MS)-driven approach to identify changes in protein expression caused by the NPM/ALK fusion, we identified diverse NPM/ALK-induced changes affecting cell proliferation, ribosome synthesis, survival, apoptosis evasion, angiogenesis, and cytoarchitectural organization. MS-based findings were confirmed using Western blotting and/or immunostaining of NPM/ALK-transfected cells and ALK-deregulated lymphomas. A subset of the proteins distinguished NPM/ALK-positive ALCLs from NPM/ALK-negative ALCLs and Hodgkin lymphoma. The multiple NPM/ALK-deregulated pathways identified by MS analysis also predicted novel biologic effects of NPM/ALK expression. In this regard, we showed loss of cell adhesion as a consequence of NPM/ALK expression in a kinase-dependent manner, and sensitivity of NPM/ALK-positive ALCLs to inhibition of the RAS, p42/44ERK, and FRAP/mTOR signaling pathways. These findings reveal that the NPM/ALK alteration affects diverse cellular pathways, and provide novel insights into NPM/ALK-positive ALCL pathobiology. Our studies carry important implications for the use of MS-driven approaches for the elucidation of neoplastic pathobiology, the identification of novel diagnostic biomarkers, and pathogenetically relevant therapeutic targets.
AuthorsMegan S Lim, Mary L Carlson, David K Crockett, G Chris Fillmore, David R Abbott, Olaotan F Elenitoba-Johnson, Sheryl R Tripp, George Z Rassidakis, L Jeffrey Medeiros, Philippe Szankasi, Kojo S J Elenitoba-Johnson
JournalBlood (Blood) Vol. 114 Issue 8 Pg. 1585-95 (Aug 20 2009) ISSN: 1528-0020 [Electronic] United States
PMID19531656 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Proteome
  • p80(NPM-ALK) protein
  • Protein-Tyrosine Kinases
  • Ribosomal Protein S6 Kinases
Topics
  • Amino Acid Sequence
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Jurkat Cells
  • Lymphoma, Large-Cell, Anaplastic (metabolism)
  • Metabolic Networks and Pathways (genetics, physiology)
  • Models, Biological
  • Molecular Sequence Data
  • Protein-Tyrosine Kinases (genetics, metabolism)
  • Proteome (analysis, metabolism)
  • Proteomics
  • Ribosomal Protein S6 Kinases (chemistry, metabolism)
  • Tissue Array Analysis
  • Transfection
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: